Talking to Cancer Patients About Combination Chemotherapy

Video Library —July 27, 2021
Megan Price, MSN, APRN, FNP-C
Baylor Charles A. Sammons Cancer Center
Dallas, TX
Virginia Seery, CRNP, MSN
Beth Israel Deaconess Medical Center, Harvard Medical School Teaching Hospital, Boston, MA
Laura Wood, RN, MSN, OCN
Cleveland Clinic Taussig Cancer Center
Cleveland, OH
The practice of using combinations of drugs in chemotherapy is not new and continues to evolve to include immune checkpoint inhibitors. Drug combinations can be more effective than single-agent therapy and may also reduce the risk of developing resistance. However, combining multiple drugs may increase the risk of drug interactions. Please join Laura Wood, RN, MSN, OCN, Megan Price, MSN, APRN, FNP-C, and Virginia Seery, MSN, RN, ANP-BC, AOCNP, as they discuss how they have a conversation with their patients about the benefits and risks of using drug combinations in anticancer therapy.
Related Articles
Educating Patients About First-Line Treatment Options for Advanced Renal-Cell Carcinoma
Laura Wood, RN, MSN, OCN, Megan Price, MSN, APRN, FNP-C, Virginia Seery, CRNP, MSN
|
Video Library
Megan Price, MSN, APRN, FNP-C, and Virginia Seery, MSN, RN, ANP-BC, AOCNP, discuss their approach to conversations with patients and families regarding first-line therapy for advanced renal-cell carcinoma. They also describe what resources they share with patients to help them after the initial consultation.
End-of-Life Care: Moving Beyond Practical Needs of Patients to Emotional Needs of People. An Interview with Kelly Grosklags, LICSW, BCD, FAAGC
Kristin Siyahian
|
August 2021 Vol 12, No 8
An interview with the creator of the award-winning documentary “Dying Is Not Giving Up.”
Advanced Care Practitioners Take a Lead in Improving Quality of Life and Patient Satisfaction for Cancer Patients
Video Library
Maintaining quality of life for cancer patients means different things to different cancer patients. However, the conversation starts with helping patients manage their expectations regarding their therapy and how it will impact their quality of life. Please join Laura Wood, RN, MSN, OCN, Megan Price, MSN, APRN, FNP-C, and Virginia Seery, MSN, RN, ANP-BC, AOCNP, as they examine the many ways that they collaborate with their oncology team colleagues to assess and review how an individual patient’s treatment regimen is influencing that patient’s quality of life.
Last modified: August 13, 2021

Subscribe to the Journal of Oncology Navigation & Survivorship®

To sign up for our print publication or e-newsletter, please enter your contact information below.

  • First Name *
    Last Name *
     
     
    Profession or Role
    Primary Specialty or Disease State
    Country
  • Please enter your mailing address.

    Address
     
    Address Line 2
    City
     
    State
    Zip Code